Cladis Investment Advisory, LLC - SIO GENE THERAPIES INC ownership

SIO GENE THERAPIES INC's ticker is SIOX and the CUSIP is 829399104. A total of 1 filers reported holding SIO GENE THERAPIES INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Cladis Investment Advisory, LLC ownership history of SIO GENE THERAPIES INC
ValueSharesWeighting
Q1 2023$32,320
+49623.1%
80,000
-46.7%
0.03%
-54.1%
Q4 2022$65
-100.0%
150,000
-72.8%
0.07%
-62.8%
Q3 2022$155,000
-41.5%
552,000
-25.1%
0.20%
-36.0%
Q2 2022$265,000
-64.9%
737,000
-34.5%
0.31%
-56.9%
Q1 2022$754,000
-47.1%
1,126,000
+2.0%
0.72%
-45.1%
Q4 2021$1,424,0001,104,0001.31%
Other shareholders
SIO GENE THERAPIES INC shareholders Q3 2023
NameSharesValueWeighting ↓
Sassicaia Capital Advisers LLC 310,500$863,0001.79%
Consonance Capital Management LP 3,186,335$8,858,0000.83%
Opaleye Management Inc. 2,000,000$5,560,0000.73%
Sio Capital Management, LLC 886,665$2,465,0000.50%
Rubric Capital Management LP 2,335,200$6,492,0000.48%
Affinity Asset Advisors, LLC 250,000$695,0000.37%
GSA CAPITAL PARTNERS LLP 354,265$985,0000.16%
Hudson Bay Capital Management LP 3,200,000$8,896,0000.05%
Insight Advisors, LLC/ PA 24,000$67,0000.02%
Maven Securities LTD 86,788$246,0000.02%
View complete list of SIO GENE THERAPIES INC shareholders